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The cloning, purification, and characterization of
MagIII, a 3-methyladenine DNA glycosylase from Heli-
cobacter pylori, is presented in this paper. Sequence
analysis of the genome of this pathogen failed to identify
open reading frames potentially coding for proteins
with a 3-methyladenine DNA glycosylase activity. The
putative product of the HP602 open reading frame, re-
ported as an endonuclease III, shares extensive amino
acid sequence homology with some bacterial members
of this family and has the canonic active site helix-hair-
pin-helix-GPD motif. Surprisingly, this predicted H. py-
lori endonuclease III encodes a 25,220-Da protein able to
release 3-methyladenine, but not oxidized bases, from
modified DNA. MagIII has no abasic site lyase activity
and displays the substrate specificity of the 3-methylad-
enine-DNA glycosylase type I of Escherichia coli (Tag)
because it is not able to recognize 7-methylguanine
or hypoxanthine as substrates. The expression of the
magIII open reading frame in null 3-methyladenine gly-
cosylase E. coli (tag alkA) restores to this mutant partial
resistance to alkylating agents. MagIII-deficient H. py-
lori cells show an alkylation-sensitive phenotype. H. py-
lori wild type cells exposed to alkylating agents present
an adaptive response by inducing the expression of
magIII. MagIII is thus a novel bacterial member of the
endonuclease III family, which displays biochemical
properties not described for any of the members of this
group until now.
Living organisms have developed a variety of strategies for
protecting their genetic information. DNA, the repository of
this information in all cells, is constantly exposed to chemical
challenges (1). A variety of reactive intracellular and environ-
mental compounds can induce modifications in the DNA bases.
If left uncorrected, these lesions may cause mutations or impair
DNA replication. In the case of alkylating agents, such as the
cellular methyl donor S-adenosylmethionine or genotoxic com-
pounds such as dimethylsulfate (DMS),1 methylmethanesul-
fonate (MMS), or N-methyl-N9-nitro-N-nitrosoguanidine
(MNNG), they can react nonenzymatically with DNA to pro-
duce 7-methylguanine (7-MeG) and 3-methyladenine (3-MeA)
among other alkylated bases (2). In particular, 3-MeA posses a
serious problem to the cell because it blocks DNA synthesis
(3–6). To eliminate this kind of modified base, most cells pos-
sess monofunctional DNA glycosylases that specifically recog-
nize and excise the methylated bases from DNA by cleavage of
the C19-N glycosylic bond. This first step of base excision repair
is followed by the repair of the resulting abasic (AP) site by
excision/replacement DNA synthesis.
At least four different classes of 3-MeA glycosylases have
been described, based on their sequence and substrate speci-
ficities (7). All of these are low molecular weight enzymes, and
no associated AP lyase activity has been attributed to any of
them. In Escherichia coli, the two first classes are represented.
Class I is defined by the product of the tag gene that codes for
a constitutive 3-MeA DNA glycosylase (8, 9). Tag is quite spe-
cific for the removal of 3-MeA, although 3-MeG would also be
excised with a much lower efficiency in vitro (10). Class II is
typified by the AlkA enzyme of E. coli. There is no amino acid
sequence similarity between class I and II 3-MeA DNA glyco-
sylases. AlkA has a much broader substrate specificity, being
able to release not only 3-MeA but also 7-MeG, 3-MeG, 7-MeA,
and O2-methylpyrimidines (11). In the last few years, it has
been found that AlkA has the ability to act on a variety of
modified bases other than the classical alkylation damaged.
Among those, the alkA product can release oxidized bases from
DNA (12), as well as deamination products of adenine such as
hypoxanthine (13) or ethenopurines (14, 15). Berdal et al. (16)
have shown that AlkA is even able to release normal bases from
DNA. Another difference with Tag resides in the fact that alkA
is induced by treatment of the cells with alkylating agents (7).
This induction occurs through activation of the alkA promoter
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by the Ada protein. Class III is typified by the mammalian
methylpurine DNA glycosylases. These enzymes are biochem-
ically quite similar to AlkA but differ markedly in their pri-
mary sequence. The recent determination of the crystal struc-
tures for the human 3-MeA glycosylase AAG (17) and the
bacterial AlkA (18, 19) confirmed that class II and class III
enzymes are structurally unrelated, despite the fact that they
share a broad substrate specificity. Indeed, for its structure,
AlkA belongs to the superfamily of DNA glycosylases, the ar-
chetype of which is the EndoIII from E. coli, an N-glycosylase
that excises oxidized pyrimidines from DNA (18). This struc-
tural correspondence is striking in view of the limited homology
between the members of this family, restricted to the helix-
hairpin-helix (HhH) motif present opposite a catalytic aspartic
acid in the active site. A fourth class of 3-MeA glycosylases has
been proposed after the identification of the MpgII enzyme
from Thermotoga maritima (20). This enzyme, as in the case of
AlkA, belongs to the superfamily of the EndoIII, as defined by
the HhH aspartic motif (21, 22), is able to release not only
3-MeA but also 7-MeG from N-methyl-N-nitrosourea-treated
DNA; and lacks an AP endonuclease activity. Despite those
similarities, the lack of sequence homology to AlkA, other than
the HhH aspartic motif, has prompted the authors to define the
class IV of 3-MeA DNA glycosylases (20).
In our search for new members of the EndoIII family in
Helicobacter pylori, we identified an open reading frame (ORF),
HP602, that although labeled as EndoIII (23, 24), codes for an
enzyme that does not recognize oxidized bases or AP sites as
substrates. The lack of potential methylpurine DNA glycosy-
lase-encoding genes in the genomic sequence of this pathogen,
together with the fact that the protein coded by this ORF has
the HhH aspartic motif but lacks the lysine at the active site
and the canonical 4Fe-4S cluster characteristic of endonuclease
III, prompted us to investigate the possibility that ORF HP602
could be the gene for a methylpurine DNA glycosylase. We
present here data showing that the enzyme coded by ORF
HP602 is a functional 3-MeA DNA glycosylase, MagIII, induc-
ible at the transcriptional level by MNNG. During the prepa-
ration of this manuscript and based on its sequence, the prod-
uct of this ORF was attributed to the MpgII group (20).
Although it presents predicted structural similarities with
members of the HhH aspartic motif superfamily also displayed
by AlkA and has an overall sequence similarity to the members
of the MpgII class, this 3-MeA DNA glycosylase has a more
restricted substrate specificity, comparable to the one charac-
teristic of Tag. These characteristics suggest that this enzyme
from H. pylori defines a novel class of 3-MeA DNA glycosylases.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Media, and Plasmids—-Strains used in this study
are listed in Table I. E. coli strains were grown in Luria-Bertani (LB)
broth or agar supplemented with ampicillin (200 mg/ml) or kanamycin
(30 mg/ml); Minimal A salts were prepared as described by Miller (25).
H. pylori strains were grown on blood brucella agar plates at 37 °C in a
5% CO2 and 95% humidity atmosphere. Disruption mutant H. pylori
strains were cultured with 20 mg/ml kanamycin. pGEX-4T-1 and
pET29a(1) were obtained from Amersham Pharmacia Biotech and
Novagen, respectively.
Materials and Reference Compounds—All chemicals were, unless
otherwise stated, from Sigma. [32P]ATP (3000Ci/mmol), [3H]dimethyl
sulfate (3.8 Ci/mmol), and Nensorb-20 nucleic acid purification car-
tridges were from New England Nuclear. T4 polynucleotide kinase, T4
DNA ligase, and restriction enzymes were purchased from New Eng-
land Biolabs.
pGHP602-I or pGHP602-V Construction—The magIII gene with its
own start codon was synthetized by PCR from two independent H.
pylori isolates (13/5 and ADM1 strains) by using oligonucleotide prim-
ers deduced from the HP602 ORF. The amplified DNA was cloned in
pGEX-4T-1 previously digested with restriction enzymes BamHI and
PstI. The resulting plasmids, termed pGHP602-I and pGHP602-V, were
expressed in E. coli as a fusion protein consisting of MagIII with
glutathione S-transferase (GST) at its N terminus. In each case, the
nucleotide sequences of the cloned genes were confirmed by
dideoxynucleotide sequencing.
Sensitivity to Methylmethane Sulfonate—Plasmids pGHP602-I and
pGHP602-V and the vector were independently introduced by electro-
poration into E. coli GC4803 (4). Overexpression of the proteins coded
by the plasmids after induction with 1 mM isopropyl-b-D-thiogalactopy-
ranoside (IPTG) was confirmed by SDS-polyacrylamide gel electro-
phoresis (SDS-PAGE). Survival curves were made with individual
transformants. Independent transformants and the wild type strain
GC4801 were incubated for 3 h with IPTG to allow gene expression.
They were subsequently challenged with 0, 5, 10, 25, or 50 mM MMS in
minimal A salts for 20 min at 37 °C and spread, after appropriate
dilution, on LB plates to calculate cell viability. For H. pylori strains,
evaluation of the resistance to the cytotoxic effect of the MMS was
conducted by determining the survival rate of the wild type and mutant
strains following a 20-min exposure in liquid to different concentrations
of MMS (10–100 mM), spreading on blood agar plates, and colony
counting.
Overproduction and Purification of 3-Methyladenine DNA Glycosy-
lase III—Both alleles of magIII gene (GIG and GVG) were subcloned
from pGHP602-I or pGHP602-V into pET29a1 (Novagen, Inc.) using
BamHI and PstI restriction sites. The resulting plasmids were named
pSHP602-I and pSHP602-V, respectively. E. coli BL21 cells were elec-
trotransformed with plasmids pSHP602I, pSHP602V, and pET29a1.
The expression of the S-tag-MagIII fusions in E. coli was confirmed by
S-tag Western blot according to the manufacturer’s instructions. Cells
were used to inoculate 500 ml of LB medium supplemented with kana-
mycin and were incubated at 37 °C with shacking until the A600 reached
1. IPTG was added to a final concentration of 1 mM, and growth was
continued overnight at 18 °C with shaking. Cells were harvested by
centrifugation at 4000 3 g, and MagIII was purified following the
instructions of the S-tag thrombin kit (Novagen, Inc.) except that 50 mM
KCl, 1 mM dithiothreitol, and 5% glycerol were added to all buffers. The
thrombin eluted fractions were concentrated by Centricon-30 (Amicon)
and loaded onto a fast protein liquid chromatography HR10/30 Super-
dex 75 gel filtration/size exclusion column (Amersham Pharmacia Bio-
tech) equilibrated with 50 mM HEPES, pH 7.5, 100 mM KCl, 5 mM
dithiothreitol, and 5% glycerol. The column was eluted with 30 ml of the
same buffer (0.7 ml/min), and 500-ml fractions were collected. Protein
elution profile was followed with a UV monitor. Under these conditions,
purified MagIII eluted at 12 min. Protein concentrations were deter-
mined by the Bradford protein assay method (26).
DNA Substrates—The 34-mer oligodeoxyribonucleotides used in this
study have the following sequence: 59-GGCTTCATCGTTGTCXCAGAC-
CTGGTGGATACCG-39, where X represents uracil, hypoxanthine (Hx),
TABLE I
Bacterial strains used in this work
Strain Relevant genotype Source or reference
E. coli
BL21 F ompT hsdSB(rB
2mB
2) gal dcm Novagen
GC4801 AB 1157, X::Tn5 4
GC4803 AB 1157, X::Tn5, alkA1, tagA1 4
H. pylori
13/5 Wild type Laboratory collection
ADM1 Wild type Laboratory collection
HAS141 Wild type Laboratory collection
HAS141 magIII magIII This work
26695 Wild type 24
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or dihyrothymine residue. Except for the latter, a kind gift from Dr. J.
Cadet (Commissariat a` l’Energie Atomique, Grenoble, France), these
oligonucleotides and their complements with each of the four bases
opposite the lesion in the duplex were purchased from Oligo Express
(Grenoble, France). To generate AP sites, the uracil-containing duplex
was incubated in the presence of uracil DNA glycosylase (27). The
[3H]DMS-poly(dG-dC)zpoly(dG-dC) and [H3]DMS-DNA were prepared
as described (28, 29).
Enzymatic Activity Assays—For the cleavage of lesion-containing
DNA duplexes, the oligonucleotide carrying the modified base was
32P-labeled at the 59-end and annealed to its complementary strand as
described (27). In a standard reaction (final volume, 10 ml), 50 fmol of
labeled duplex were incubated in the reaction buffer (25 mM Tris-HCl,
pH 7.6, 2 mM Na2EDTA, 50 mM NaCl) with the indicated protein
fraction at 37 °C. For Hx- and dihydrothymine-containing oligos, reac-
tions were stopped by the addition of 0.2 N NaOH. In the case of oligos
harboring an AP site, 10 mM NaBH4 was added to stabilize the sub-
strate. After addition of 6 ml of formamide dye, the products were
separated by 7 M urea 20% PAGE. Gels were analyzed by
autoradiography.
3-Methylpurine DNA glycosylase activities were determined by the
method of Karran et al. (30). The reaction mixture (50 ml) contained 50
mM HEPES-KOH (pH 7.5), 5 mM dithiothreitol, 1 mM Na2EDTA, 100
mM KCl, and 2000 or 15,000 cpm of [3H]DMS-DNA or [3H]DMS-
poly(dG-dC)zpoly(dG-dC) (2000 cpm/pmol). The reaction mixture was
incubated at 37 °C for 30 min, and then 75 ml of stop solution containing
1 mg/ml bovine serum albumin, 1 mg/ml salmon testes DNA, and 0.5 M
NaCl were added, followed by the addition of 500 ml of cold ethanol. The
reactions were kept at 220 °C for 15 min and centrifuged, and the
supernatants were taken (ethanol soluble fraction). The radioactivity in
the soluble fraction was determined in a liquid scintillation counter. To
analyze the products, the reaction mixtures were separated using high
pressure liquid chromatography (HPLC) (4, 6). The internal nonradio-
active markers 3-MeA and 7-MeG were added to the samples and
detected by their UV absorbance. The radioactivity in the fractions was
determined in a liquid scintillation counter.
Construction of an H. pylori Mutant Deficient in 3-Methyladenine
DNA Glycosylase—The HP602 ORF was amplified by PCR from the
genomic DNA from strain 26695 (24) using the forward 59-CAUCAU-
CAUTGTGTTGGATAGTTTTGAGAT (602-F) and the reverse 59-
CUACUACUAAAATCAAAGTTTTAATTCCAA (602-R) oligonucleo-
tides. The 650-base pair DNA product was cloned in the pILL570
derivative plasmid (3.6 kilobase) following a treatment with Uracil
DNA Glycosylase (Roche Molecular Biochemicals), producing 39-pro-
truding ends on both the amplicon and the vector (31). The cloned ORF
was disrupted in E. coli by insertion of a transposable element
(MiniTn3-Km) (32) into the recombinant plasmid. Twenty-four inde-
pendent disruptions of the pILL570-HP602 plasmid were pooled and
purified using MIDI columns (Qiagen). The pooled plasmids were in-
troduced by natural transformation (33) into H. pylori strain HAS141
(34). Chromosomal DNA from six individual kanamycin resistant trans-
formants were purified (QIAamp tissue kit, Qiagen) and used as tem-
plate for PCR using the 602-F primer together with Km-1 (59-CGG-
TATAATCTTACCTATCACCTCA) or Km-2 (59-TTTGACTTACTGGGG-
ATCAAGCCTG), two divergent primers flanking the kanamycin resist-
ance gene of the kanamycin cassette (35). Each PCR fragment was
directly sequenced with primer Km-3 (59-GATCCTTTTTGATAATCTC-
ATGACC, complementary to the end of the MiniTn3-Km), allowing us
to determine the orientation of the transposon as well as the precise site
of insertion of the transposable element within the HP602 ORF. One
mutant with an insertion at nucleotide 1272 of the HP602 ORF was
further characterized (mutant designated through the manuscript as
HAS141 magIII).
Semiquantitative Reverse Transcription-PCR—Two-day-old H. pylori
plates were independently challenged with 50 mg/ml MNNG, 5 mg/ml
MMS, or 0.5 mg/ml DMS. After 0 min, 20 min, 1 h, 2 h, or 4 h, the cells
were harvested, rinsed twice, and frozen in liquid nitrogen. The cell
pellets were stored at 270 °C. RNA extraction from frozen H. pylori
HAS141 was performed with guanidinium thiocyanate-phenol chloro-
form (Trizol, Life Technologies, Inc.). Total RNA was dissolved in 20 ml
of diethyl pyrocarbonate-treated water and incubated at 37 °C for 30
min with 1 unit/ml RNase-free DNase (Promega). DNA absence was
confirmed by PCR. cDNA was synthetized with 2 pmol of reverse
specific primers for 16 S RNA and magIII, added to 1 mg of each RNA
sample. The mixtures were incubated at 70 °C for 10 min, placed on ice
for 2 min, and incubated with Superscript II reverse transcriptase (Life
Technologies, Inc.) according to the manufacturer’s recommendations.
Reverse primers were as follows: for 16 S RNA, 59-CTGGAGAGACTA-
AGCCCTCC-39; for magIII, 59-TTTTTTCTGCAGAAGTTTTAAT-39.
Relative quantification of mRNA levels was performed in the exponen-
tial phase of amplification as described previously (36). Briefly, PCR
amplification of target template and of 16 S RNA as external control
were run in parallel. DNA amplification was carried out in 13 PCR
buffer supplemented with 200 mM dNTPs, 2 mM each of 59- and 39-
specific primers, 1 unit of Taq polymerase (Roche Molecular Biochemi-
cals) in a final volume of 50 ml. The exponential phase of amplification
was determined by carrying out the reaction for 16–38 cycles using a
fixed quantity of cDNA. The number of cycles was set for magIII to 26
sequential cycles at 95 °C for 30 s, 48 °C for 45 s, 72 °C for 40 s, and for
16 S RNA to 20 cycles at 95 °C for 30 s and 60 °C for 30 s. In this phase
of amplification, the amounts of the amplicons are proportional to the
initial amounts of templates. The cDNA was serially diluted in water
from 1:5 (10 ng of RNA) to 1:15625 (3.2 pg of RNA). 20 ml of magIII and
16 S RNA PCR products amplified in parallel from the same serial
dilutions were loaded on agarose gel (1% agarose, 0.05% ethidium
bromide). A negative control in which cDNA was omitted was run in
parallel with each experiment.
RESULTS
Identification of a New Member of the Endonuclease III Gly-
cosylase Family in H. pylori—The availability of the complete
genomic sequence of H. pylori allowed us to identify several
putative members of the EndoIII family of DNA glycosylases
involved in the repair of modified bases. Two open reading
frames were annotated as homologs of the EndoIII from E. coli,
HP602 and HP585 (24). To analyze whether these two ORFs
coded for bona fide homologs of the EndoIII and whether they
corresponded to redundant activities, the putative coding se-
quences from two independently isolated strains (13/5 and
ADM1) were amplified by PCR and cloned in E. coli vectors
that allow their expression as fusions to the C terminus of the
GST protein. For HP585 the purification of the GST fusion
protein confirmed that this ORF codes for an active EndoIII-
like enzyme (data not shown). Sequencing of the plasmids
harboring the HP602 ORFs established that the sequences
differed between the two isolates (Fig. 1). Comparison of the
coded proteins and those of the two strains of which the ge-
nomes are completely sequenced shows that for any pair, there
are four or five amino acid differences among the 218 residues.
In particular, for the two newly sequenced ORFs, a polymor-
phism was found, GIG versus GVG, at what has been deter-
mined to be the active site for the members of this family (22)
(HhH motif, Fig. 1). As a consequence, the analysis of both
clones (herein denominated 602-I and 602-V) was carried out in
parallel. HP602 also presented regions (Fig. 1) structurally
homologous to the EndoIII. The three-dimensional PSSM web
server was searched for HP602 structurally related proteins.
The strongest structural similarities were found with respect to
EndoIII (E value, 2.7 3 1023) and AlkA (E value, 2.8 3 1022)
crystals (37, 38). In the predicted secondary structure of the
HP602 product it is possible to define, with a high level of
confidence ($50%) the helices aC to aM of EndoIII and AlkA,
which constitute the regions at which fold and topology are
shared by both enzymes (18) (Fig. 1). Moreover, identical amino
acids are clustered over these conserved secondary structures.
However, HP602 product lacks the pattern of cysteines giving
rise to the iron-sulfur cluster present in EndoIII and MpgII
proteins. No activity was detected on DNA substrates contain-
ing dihydrothymine for the product of the GST fused to either
of the HP602 ORF variants (data not shown). Furthermore,
neither of these constructs was able to complement the mutator
phenotype of an E. coli strain deficient in both EndoIII and
EndoVIII DNA glycosylases (data not shown). We therefore
examined whether these ORFs could code for a function related
to the other member of the EndoIII family, AlkA, which also
shares a similar overall folding pattern with EndoIII, as well as
the HhH aspartic motif (Fig. 1).
Complementation of an E. coli alkA tag Mutant—To examine
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whether H. pylori HP602 can substitute for E. coli AlkA and/or
Tag in the repair of damaged DNA, HP602/GIG or HP602/GVG
fused to GST were expressed in E. coli GC4803 (4), a strain
phenotypically sensitive to alkylating agents due to null muta-
tions in tag and alkA. To confirm that the proteins were ex-
pressed, SDS-PAGE analyses of crude E. coli extracts were
performed (data not shown). Independent transformants for
each plasmid and the isogenic wild type strain GC4801 were
incubated for 3 h with IPTG to allow gene expression and were
subsequently challenged with 0, 5, 10, 25, or 50 mM MMS
before spreading on LB plates to calculate the survival fraction.
Fig. 2 shows that both HP602-I and HP602-V products are able
to partially restore the wild type resistance to MMS in the alkA
tag double mutant. Although it represents only the 10–15% of
the DNA alkylation products, 3-MeA is considered to be the
major cause for the cytotoxicity induced by alkylating agents
(7). This result indicates that ORF HP602 is likely to code for a
protein with a 3-MeA DNA glycosylase activity.
Substrate Specificity of HP602 Gene Product—To further
investigate the characteristics of these DNA glycosylases, the
crude extracts of E. coli GC4803 harboring the pGHP602-I or
pGHP602-V plasmid or the vector were assayed for their ability
to liberate tritiated bases from [3H]dimethyl sulfate-treated
DNA or poly(dG-dC)zpoly(dG-dC) (Table II). Both enzymes were
able to release methylpurines from [3H]DMS-DNA but not from
[3H]DMS-poly(dG-dC)zpoly(dG-dC). This difference in the sub-
strate specificity suggested that MagIII could not recognize
7-MeG, the major alkylation product. We therefore named the
corresponding gene magIII for 3-MeA DNA glycosylase.
In order to unambiguously characterize the substrate speci-
ficities, HP602-I and HP602-V were subcloned into pET29a1
(Novagen, Inc.) to yield pSHP602-I and pSHP602-V, respec-
tively. The plasmids encode the fusion proteins Sztag-MagIII(I)
and Sztag-MagIII(V), respectively. This allowed the isolation of
the fusion peptide and subsequent cleavage and purification of
the native protein. The SDS-PAGE protein profile, after induc-
tion with 1 mM IPTG, showed a prominent band of about 26.5
kDa that was present in cells carrying pSHP602-I and
pSHP602-V but absent when pET29a1 was present in the
same strain. After purification of the fusion protein, the throm-
bin-eluted fractions were concentrated and loaded onto a Su-
perdex 75 column. Both MagIII proteins were purified to yield
FIG. 2. Sensitivity to MMS exposure of a tag alkA E. coli mu-
tant strain expressing ORF HP602. Survival curves for E. coli
GC4803 (tag alkA) harboring pGEX-4T1 (3), pGHP602-V (f), or
pGHP602-I () and the parental wild type strain ( l ) incubated for 20
min with the indicated amounts of MMS in liquid medium.
TABLE II
Methylpurine DNA glycosylase activity in crude lysates of E. coli 4803






E. coli 4803 pGEX-4T1 29 0
E. coli 4803 pGHP6021 45 257a
E. coli 4803 pGHP602V 41 243a
AlkA 1169 1758
a This value corresponds to the total content of 3-MeA available as
substrate.
FIG. 1. MagIII (HP602) sequence analysis. The alignment of the HP602 coded protein from four different isolates is presented. 13/5 and
ADM1 were obtained in this work, and 26695 and JHP correspond to the isolates of which the genomes were completely sequenced (23, 24). The
predicted secondary structures shared with the crystallographic data obtained for EndoIII and AlkA are shown beneath the alignment; residues
involved in these structures are gray-shaded. The putative HhH motif is double-boxed. Amino acids marked with a star are identical to EndoIII.
Positions marked with a diamond are identical to AlkA. Amino acids marked with an asterisk are identical to both enzymes. Boldface letters
highlight intraspecies changes. These data were generated by the three-dimensional PSSM web server, by the Biomolecular Modelling Laboratory,
Imperial Cancer Research Fund (38), and according to the Labahn et al. (18) EndoIII/AlkA comparison.
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a single Coomassie Blue-stained band migrating in SDS-PAGE
with a molecular mass of 25 kDa, which corresponds to the
full-length protein coded by the ORF HP602 (Fig. 3). The ca-
pacities of both purified forms of MagIII to release specific
modified bases from [3H]DMS-DNA were examined using
HPLC. Fig. 4 shows that MagIII is able to release 3-MeA but
not 7-MeG from alkylated DNA, which is consistent with the
lack of activity on [3H]DMS-poly(dG-dC)zpoly(dG-dC). This was
also apparent after 4 h of reaction. Under conditions where the
amounts of enzyme were normalized for their capacity to excise
3-MeA with respect to AlkA, no excision of 7-MeG was detected.
Because AlkA can also release Hx from DNA (13), a duplex
oligonucleotide harboring a unique Hx residue at a defined
position was challenged with the purified MagIII and subse-
quently treated with 0.2 N NaOH to reveal the AP site resulting
from the glycosylase activity. Fig. 5A shows that the Hx residue
is not released by MagIII at detectable rates from the modified
DNA. Similar experiments were carried out with oligonucleo-
tides harboring oxidized bases as dihydrothymine or 8-oxogua-
nine, and no glycosylase activity was detected for these sub-
strates (data not shown). To confirm the sequence prediction
that MagIII does not have an AP lyase activity, a 32P 59-end-
labeled oligonucleotide with a single abasic site opposite a
cytosine was used as a substrate. No detectable cleavage of the
oligonucleotide was observed after incubation with either of the
MagIII variants (Fig. 5B).
Disruption of the magIII from H. pylori—As mentioned
above, the examination of the complete genomic sequences of
H. pylori fails to reveal ORFs potentially coding for either
Tag-like or AlkA-like enzymes. To analyze whether the MagIII
is indeed functional in vivo and confers resistance to alkylating
agents, a disruption mutant was generated in H. pylori by
insertion of a kanamycin transposon into the ORF HP602 of
strain HAS141. The disruption of this gene was confirmed by
sequencing of the genomic DNA. HAS141 and HAS141magIII
were then treated with increasing concentrations of MMS to
study the cytotoxic effect of the alkylating agent. Fig. 6 shows
survival reduction of the mutant strain by concentrations of
MMS that do not affect the survival of the parental strain. This
result demonstrates that in H. pylori, MagIII is the main de-
fense against the presence of 3-MeA generated by alkylating
agents on DNA.
Adaptive Response of H. pylori to Alkylating Agents—The
possibility of an adaptive response to the challenge by alkylat-
ing agents was explored by analyzing the levels of magIII
transcripts in wild type H. pylori after treatment with suble-
thal doses of alkylating agents as DMS, MMS, or MNNG. As
shown in Fig. 7, semiquantitative reverse transcription-PCR
experiments show that exposure to 50 mg/ml MNNG induced at
least a 5-fold increase of the levels of magIII transcripts. Ex-
periments using 1:4 serial dilutions revealed that the increase
of magIII mRNA induced by exposure to MNNG is between 16-
and 24-fold. There was no induction of magIII mRNA after
treatment of the cells with either DMS or MMS.
DISCUSSION
H. pylori is a Gram-negative bacterium that is associated with
several human pathologies (39). Indeed, gastric inflammation
and peptic ulcer (40, 41), as well as predisposition to gastric
cancer and non-Hodgkin lymphomas of the stomach (42, 43),
have been linked to infection by this pathogen. Almost half of
the population of the world harbors an H. pylori infection.
There is considerable evidence that the bacterial genotype is an
important factor in determining the nature and severity of the
disease induced by the infection (44, 45). The availability of the
complete genomic sequences of two strains (23, 24) allows not
only the comparison of the genomes to other organisms se-
quences but also a preview of the intraspecies variations in
FIG. 3. SDS-PAGE and Western blot analysis of S-tag and pure
MagIII. A, red Ponceau-stained polyvinylidene fluoride membrane (of a
10% SDS-PAGE). Molecular size markers are indicated. Lane 1, 15 mg
of MagIII/GIG; lane 2, 15 mg of MagIII/GVG; lane 3, induced BL21
pGHP602-I; lane 4, induced BL21 pGHP602-V; lane 5, induced BL21
pET29a1. B, S-tag-directed Western blot of the membrane shown in A.
FIG. 4. Reverse phase HPLC of methylated bases released from
[3H]dimethyl sulfate-treated DNA. Incubations with MagIII/GIG
(), MagIII/GVG (f), AlkA ( l ), or denatured enzyme (3) were carried
out for 30 min at 37 °C. Radioactivity measured in ethanol superna-
tants from the heat denaturing of the substrate is indicated by the
dotted line.
FIG. 5. Enzymatic activities on oligonucleotide substrates. A,
repair of hypoxanthine by MagIII. Lane 1, 10 mg of MagIII/GIG; lane 2,
10 mg of MagIII/GVG; lane 3, 1 mg of pure AlkA; lane 4, reaction carried
out with denatured MagIII as negative control. B, AP lyase activity of
MagIII. Lane 1, 5 mg of MagIII/GIG; lane 2, 5 mg of MagIII/GVG; lane
3, reaction carried out with denatured MagIII as negative control; lane
4, 2 mg of EndoIII. S and P indicate substrate and product, respectively.
FIG. 6. Sensitivity of H. pylori to MMS. Survival curves for H.
pylori HAS141/magIII (clone 5) (), HAS141/magIII (clone 7) (f), and
the parental wild type strain ( l ) incubated for 20 min with increased
amounts of MMS in liquid medium. Data are representative of two
independent experiments.
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their coding sequences. As an example, Fig. 1 shows that in the
magIII gene, there are single amino acid variations between
isolates at seven positions. The genetic variability of H. pylori
has been the focus of many investigations (39, 46). The study of
natural isolates suggests that the genetic diversity of H. pylori
exceeds the level of diversity recorded in virtually all other
bacterial species studied. It has been concluded that the pres-
ence of ORFs with the capacity to code for DNA repair enzymes
preclude point mutations as a possible cause of the genetic
diversity. However, the inference of a gene function by se-
quence homology can lead to misinterpretation. This is the case
especially when the homologies invoked are not to proteins for
which experimental evidence of their function exists but rather
to proteins for which the function has been inferred from their
homology to other sequences. Moreover, in the case of H. pylori,
the presence of some genes involved in particular DNA repair
pathways has been identified without finding the other func-
tions for the same pathway. In the case of the mismatch repair
system, a MutS homolog has been predicted, but no ORF en-
coding a MutL-like protein has been identified. From the ge-
nome analysis, several enzymes from the base excision repair
pathway also seem to be missing; there are no Fpg homologs
(although there is a putative MutY coding sequence), and no
ORF has been predicted as coding for the repair of alkylated
bases by base excision repair. The description in this paper of a
3-MeA DNA glycosylase from H. pylori underscores the limita-
tions of negative predictions about the presence of functions
based on sequence comparisons.
MagIII was originally attributed an endonuclease III-like
function because of the presence of the GI/VG motif and the
aspartic acid at position 150 that are the signature of the
superfamily of DNA glycosylases resembling EndoIII (22, 47,
48). However, it lacks the 4Fe-4S cluster characteristic of all
the EndoIII proteins described. It is shown here that MagIII is
not a functional EndoIII because it does not recognize oxidized
pyrimidines as substrates and does not have an AP lyase ac-
tivity. We have established that MagIII is, however, a mono-
functional 3-MeA glycosylase belonging to the EndoIII family of
DNA glycosylases. Although the E. coli class II 3-MeA glycosy-
lase AlkA is also a member of this superfamily, no significant
primary sequence similarity is found between these proteins.
Moreover, they differ significantly in their substrate specifici-
ties. While this work was in progress, Begley et al. (20) de-
scribed yet another 3-MeA DNA glycosylase, MpgII from T.
maritima, defining what they called class IV. They also sug-
gested that the putative protein coded by ORF HP602 (MagIII)
from H. pylori could belong to class IV of the 3-MeA DNA
glycosylases by sequence similarity (28% identity). The most
conserved structure is the HhH (G/P)X18-21D motif, the pres-
ence of which suggests that MagIII may use a common mech-
anism of base excision by nucleophilic activation. However,
MagIII shows an important difference in lacking the iron-
sulfur cluster, which has been implicated in DNA phosphate
backbone recognition. At the sequence level, the 28% identity is
not much higher than the level of identity between MpgII and
MutY or EndoIII (25 or 20%, respectively). Indeed, MpgII
shares a greater homology with other members of its subclass,
such as the enzyme from Methanococcus jannaschi (43% iden-
tity), that lack the iron-sulfur cluster. MagIII substrate speci-
ficity is also different. Unlike MpgII and AlkA, MagIII does not
excise 7-MeG. Moreover MagIII does not recognize Hx as sub-
strate. Taking into account the alkylated lesions tested, MagIII
seems to recognize almost exclusively 3-MeA, defining then a
substrate specificity closer to the class I 3-MeA glycosylases
such as Tag (7, 49). We therefore suggest that MagIII defines a
novel class of 3-MeA glycosylases. It will be interesting to study
whether the other putative MpgII described by Begley et al.
(20) are MpgII-like or MagIII-like enzymes. This will shed light
on the sequence features responsible for the substrate
specificities.
At the physiological level, magIII, as alkA in E. coli, is
transcriptionally induced by exposure of the cells with MNNG.
This represents an enhanced protection against the cytotoxic
effects of alkylating agents. However, no homolog for the E. coli
ada gene has been reported from the sequenced genomes. The
O6-methylguanine alkyl transferase deduced from the se-
quence of ORF HP676 lacks the signal molecule found associ-
ated to it in other bacterial species (7). Extensive data base
searches using the Ada A sequence from Bacillus subtilis or the
conserved regions of all the Ada-like activators (50) failed to
detect H. pylori primary sequences with homology to them. The
mechanisms and the genes required for this adaptive response
in H. pylori remain to be found.
The construction of an H. pylori strain with a mutant allele
of magIII showed that MagIII is functional in vivo and seems to
be essential for the protection of the bacterial genome from the
effects of alkylating agents. The sensitivity displayed by the
mutants suggests that there are no efficient backup systems for
MagIII in H. pylori. The presence of MagIII allows H. pylori to
protect itself from the cytotoxic effects of 3-MeA adducts pro-
duced on DNA by the action of endogenous or environmental
alkylating agents. However, MagIII will not excise the most
abundant product generated on DNA by alkylating agents,
7-MeG. It has been suggested that this adduct, although innoc-
uous for cell survival, could have a mutagenic effect (51, 52).
This could potentially contribute to the high genetic variability
found within H. pylori.
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FIG. 7. Semiquantitative reverse transcription-PCR analysis of magIII expression in H. pylori exposed to alkylating agents. The
cells were challenged with 0.5 mg/ml DMS, 5 mg/ml MMS, or 50 mg/ml MNNG for 0, 20, 60, 120, or 240 min. Lanes for each time point correspond
to 1:5 serial dilutiions. MagIII lanes correspond to 50, 10, 2, 0.4, and 0.08 ng of cDNA template for all samples. 16S RNA lanes show the PCR
products obtained from 10, 2, 0.4, 0.08, and 0.016 ng for DMS and MMS challenge. An extra dilution (3.2 pg) for the MNNG experiment is
presented. Gels are representative of two independent experiments.
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